1 / 36

Simposio Fosforo e MBD in PD: vecchi e nuovi protagonisti Rimozione del fosforo e dialisi peritoneale Roberto R

Simposio Fosforo e MBD in PD: vecchi e nuovi protagonisti Rimozione del fosforo e dialisi peritoneale Roberto Russo. Hyperphosphatemia is a predictor of overall and CV mortality. Noordzij M et al NDT 21: 2513–2520,2006. Serum Phosphorus and Mortality in

vandana
Télécharger la présentation

Simposio Fosforo e MBD in PD: vecchi e nuovi protagonisti Rimozione del fosforo e dialisi peritoneale Roberto R

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Simposio Fosforo e MBD in PD: vecchi e nuovi protagonisti Rimozione del fosforo e dialisi peritoneale Roberto Russo

  2. Hyperphosphatemiais a predictorofoverall and CV mortality Noordzij M et al NDT 21: 2513–2520,2006

  3. Serum Phosphorus and Mortality in Dialysis Patients Ansell D et al NDT 22: 667, 2007

  4. Serum Phosphorus and Mortality in PD Patients Data on 7034 PD patientswhoattended Da Vita dialysisclinics for at least 3 months Mehrotraet al Perit Dial Int 27: Suppl 3, S12, 2007

  5. Percentageachievementof the K/DOQI guidelineforbonemetabolism 40% Calcium Phosph CaxP iPTH Noordzij M et al NDT 21: 2513–2520,2006

  6. Management ofhyperphosphatemia in PD patients • Dietaryphosphaterestriction • Removalofphosphatebydialysis and residualrenalfunction • Administrationofphosphatebinder

  7. Total body phosphate 700 g

  8. Phosphatebalance in dialyzedpatients Ketteler M, GrossML, Ritz E. KidneyInt 2005;67:s120-7

  9. Sedlacek M et al Am J Kidney Diseases 2000; 36: 1020-1024

  10. Bammens B et al Am J Kidney Dis 2005; 46: pp 512-519

  11. Superior dialytic clearance of |[beta] |2-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis Phosphateclearance • 55 L/1.73 m2 in APD 34 patients • 66 L/1.73 m2 in CAPD 16 patients Enevepoel P et al KidneyInt 2006; 70:794-9

  12. Is it possible to control hyperphosphataemiawith diet? Serum P 5.5 mg/dl PCl 57L/week 5,5 mg/dl x 57 L / sett = 3135 mg of P - 3135/7 = 447 mg 60-64 g proteine x 14-15 mg (contenuto di P x g proteine) = 960 mg/2 = 480 mg Rufino M et al NephrolDialTransplant 1998; 13(Suppl 3): 65–67

  13. Urinaryphosphateexcretion • CAPD patientsurinaryexcretion (48.8+21.4) representabout 40% of the total Pi removed • Urinary Pi excretionwaslinearlyrelatedto GFR values Messa P et al NephrolDialTransplant 1998; 13 (Suppl 6): 43–48

  14. ResidualRenalFunction and PhosphateLevels • Only 29% ofpatientswithpreserved RRF had a serumphosphateconcentration > 5.6 mg/dl ascomparedwith 44% of the anuricpatients • Residual GFR wasanimportantpredictorofserumphosphatelevels in a cross sectionalstudyofover 250 prevalent PD patients Wang AYM et al Amer J Kidney Dis 2004; 43: 712-720

  15. Urinaryphosphateexcretion Bammens B et al Amer J Kidney Dis 2005; 46: 512-519

  16. WithRRF Cumulative Survival No RRF Follow-up months Sopravvivenza dei pazienti in dialisi peritoneale Wang AYM, NephrolDialTransplant 2005

  17. Phosphatecontrolwithnocturnal HD CHD NHD Mucsi I et al KidneyInt 1998

  18. Phosphatecontrolwithnocturnal HD Lindsay RM et al Amer J Kidney Dise 2003; 42: (Suppl 1) S24-S29

  19. D/P RatioofSolutes in PD 1,0 UREA 0,9 CREATININE 0,7 PHOSPHATE D/P 0,4 8 2 4 Tempo di stazionamento (ore)

  20. Transperitonealphosphatetransport • Convention • Diffusion down anelectrochemicalgradient • Lymphaticconvectiveabsorptionisnot a factor Graff J et al ClinPhysiol 1996; 16:291-300

  21. Phosphateremoval on PD 66 mg 111 mg mg P < 0.001 Delmez JA et al Kidney Int 1982; 21: 862—867

  22. Predictorsofphosphateremoval Messa P et al NephrolDialTransplant 1998; 13 (Suppl 6): 43–48

  23. Associationbetween 24-hour UF and percentofphosphateremovedby UF Granja CA et al ContribNephrol 2009; 163:198-205

  24. PhosphateBalance in PeritonealDialysis: RoleofUltrafiltration Granja CA et al ContribNephrol 2009; 163:198-205

  25. Phosphateclearanceaccordingtoperitoneal membrane transportcharacteristic Sedlacek M et al Am J Kidney Diseases 2000; 36: 1020-1024

  26. Phosphateclearanceaccordingtoperitoneal membrane transportcharacteristic Badve SV et al Clin J Am Soc Nephrol 2008; 3: 1711–1717

  27. Relation between the D/P ratios and clearanceofphosphorus and creatinine Sedlacek M et al Am J Kidney Diseases 2000; 36: 1020-1024

  28. Determinantsofperitonealphosphateclearance, bylinearregression Badve SV Clin J Am Soc Nephrol 2008; 3: 1711–1717

  29. Phosphateclearanceaccordingtoperitoneal membrane transportcharacteristic PeritonealPhosphateClearance Badve SV Clin J Am Soc Nephrol 2008; 3: 1711–1717

  30. Phosphateclearanceaccordingtoperitoneal membrane transportcharacteristic IPD 15x2 totale 30 L - TPD (50%) 29x1 totale 30 L Piraino B et al PeritDialInt 1994; 14:145-148

  31. PeritonealPhosphateclearancesaccordingto PD modality *CCPD2 * Liters/week

  32. The impact ofvarious NIPD cycling regimens on phosphorusremoval in chronic PD patients L/1.73 m2 14 L 24 L 24 L Juergensens P et al Int J ArtifOrgans 2005;28:1219-23

  33. A comparisonofclearances on tidalperitonealdialysis and intermittentperitonealdialysis IPD 15x2 totale 30 L - TPD (50%) 29x1 totale 30 L Piraino B et al PeritDialInt 1994; 14:145-148

  34. Adequacyofautomatedperitonealdialysiswith and withoutmanual daytime exchange: a randomizedcontrolled trial P = 0.68 Dailyphosphateclearance L/1.73 m2 Demetriou D et al KidneyInt 2006; 70:1649-55

  35. Conclusions 1 • Total phosphateclearancedepends on both RRF and peritonealclearance and mayfallsubstantiallyas RRF declines • Phosphateclearances are limitedwith PD therapy • Phosphateclearance on NIPD isinferiortothat on CAPD becauseoftimedependentremovalofphosphate • High flow CCPD may produce a marginalincrease in peritonealphosphateclearance • CCPD and CCPD2 do notappeartohave major differences

  36. Conclusions 2 • Thereis a realconcernthatwithreduction in K/DOQI guidelinesto KT/V 1.7, phosphateremovalwith PD willbefurthercompromised • Topreventhyperphosphatemiamostpatientsundergoing PD requireanexogenusphosphatebinder

More Related